Dcm Advisors, LLC Idera Pharmaceuticals, Inc. Transaction History

Dcm Advisors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$0.53 - $1.03 $55,653 - $108,157	-105,007 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.0 - $1.18 $105,007 - $123,908	105,007 New	105,007 $108,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcm Advisors, LLC with notifications on news.